சையத் யாசிர் அராபத் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Ekuinas sets up RM10m fund for 4,000 micro, small Bumiputera enterprises
thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
Ekuinas records strong investment returns for 2020
thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
Malaysia s Ekuinas books $137m return from second fund in 2020
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
Malaysia’s government-owned private equity company Ekuiti Nasional (Ekuinas) has acquired a controlling stake in local drug firm Medispec for an undisclosed sum, marking its first investment in the pharmaceutical industry.
The acquisition was based on an enterprise value of 88.5 million ringgit (US$21.82 million) for Medispec, Ekuinas says in a statement on February 3. It did not disclose the size of the stake.
“Ekuinas’ entry into the healthcare and pharmaceutical space is timely as we look to capitalise on global megatrends and demographic shifts amid the emergence of Covid-19,” Chief Executive Officer Syed Yasir Arafat Syed Abd Kahir says in the statement.
Ekuinas chief executive officer Syed Yasir Arafat Syed Abd Kadir said Ekuinas’ entry into the healthcare and pharmaceutical space was timely as it looked to capitalise on global megatrends and demographic shifts amid the emergence of Covid-19.
KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) made its foray into the pharmaceutical industry with the acquisition of a controlling stake in Medispec (M) Sdn Bhd.
The government-linked private equity fund management company said the acquisition was based on an enterprise value of RM88.5mil.
Ekuinas chief executive officer Syed Yasir Arafat Syed Abd Kadir said Ekuinas’ entry into the healthcare and pharmaceutical space was timely as it looked to capitalise on global megatrends and demographic shifts amid the emergence of Covid-19.